• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/27

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

27 Cards in this Set

  • Front
  • Back
General MOAs
- Replacement therapy
- COMT inhibition
- DA releasers
- MAO-B inhibition
- DA receptor agonists
- Anticholinergics
Levodopa
- Replacement therapy
- only used in combination with carbidopa
Carbidopa/Levodopa
- Replacement therapy + inhib. of peripheral aromatic L-AA decarboxylase
- carbidopa/levodopa is effective for 2-5 years and then starts to wear off causing "on-off" effect
- AE: dose related diskinesia, pathological gambling, peripheral effects (nausea, vomiting), CNS effects (vivid dreams, hallucinations)
Tolcapone
- COMT inhib.
- Metabolism: glucuronidation
- AE: fatal hepatoxicity, diskinesia, nausea, diarrhea, urine discoloration
Entacapone
- COMT inhib.
- Can lower required dose of carbadopa/levodopa
- Metabolism: glucuronidation
- AE: diskinesia, nausea, diarrhea, urine discoloration
Amantadine
- Dopamine releaser, NMDA antagonism
- ClogP = 2.4
- Useful in early stages
- Metabolism: unchanged
- AE: nausea, dizziness, insomnia, confusion, hallucinations, psychosis at high serum levels (elderly)
Selegiline (L-deprenyl)
- irreversible inhibition of MAO-B, inhib. dopamine reuptake
- Can lower needed L-DOPA dose
- Metabolism: 2B6, 2C19 - N-dealkylation to R-methamphetamine (less potent enant.)
- AE: orthostatic hypotension, nausea, insomnia, can exacerbate AEs of L-DOPA
- Do NOT use w/ TCAs
Rasagiline
- MAO-B inhib.
- Metabolism: 1A2 - N-dealkylation to inactive
- fewer peripheral AE than selegiline
Rasagiline
- MAO-B inhib.
- Metabolism: 1A2 - N-dealkylation to inactive
- fewer peripheral AE than selegiline
DA Receptor Agonists
- Less active than L-DOPA
- Less likely to cause dyskinesia or motor fluctuations
- Can lower required L-DOPA dose
- AE: nausea (blocked by D2 antagonists e.g. domperidone), somnolence, "sleep attacks", toxic psychosis, orthostatic hypotension, confusion, pathological gambling
- Sleepiness can be combat w/ modafinil
Bromocriptine
- DA receptor agonist, 5HT2B agonist, partial D1 full D2 agonist
- Metabolism: 3A4, t1/2 = 3 hrs



Bromocriptine
- DA receptor agonist, 5HT2B agonist (cardiotoxic), partial D1 full D2 agonist
- Metabolism: 3A4, t1/2 = 3 hrs



Pergolide
- DA receptor agonist, 5HT2B agonist (cardiotoxicity), Partial D1 full D2 agonist
Ropinirol
- DA receptor agonist, full D2 and D3 agonist
- Also for RLS
- Metabolism: 1A2 - N-despropyl to inactive
Pramipexole
- DA receptor agonist, full D2 and D3 agonist
- also used for RLS
- Metabolism: 90% unchanged
Apomorphine
- DA receptor agonist, potent D1 and D2 agonist
- only approved for treatment of hypomobility ("off" episodes)
- R-enantiomer
- equivalent to L-DOPA in treatment results
- Metabolism: extensive 1st pass
- AE: similar to L-DOPA, vomiting (give trimethobenzamide 3 days before), hypersexuality
Rotigotine
- DA receptor agonist, D1 D2 and D3 agonist
- Comes TD patch only
- Metabolism: N-dealkylation, sulfonation, glucuronidation
- AE: typical for this class
Cabergoline
- DA receptor agonist
- D2, D3, and potent 5HT2B (cardiotoxic) agonist
- Metabolism: minimal CYP involvement, hydrolysis of acyl urea
Anticholinergics
- Effective in early stages of Parkinsonism
- AE:
- Peripheral: tachychardia, can't see, can't pee, can't spit, can't sh*t
- CNS: somnelence, hallucinations, impared memory, delusions, ataxia, dysarthria
Anticholinergic Drugs
- Atropine
- Benztropine
- Procyclidine
- Diphenhydramine
- Trihexyphenidyl
Ropinirol
- DA receptor agonist, full D2 and D3 agonist
- Also for RLS
- Metabolism: 1A2 - N-despropyl to inactive
Pramipexole
- DA receptor agonist, full D2 and D3 agonist
- also used for RLS
- Metabolism: 90% unchanged
Apomorphine
- DA receptor agonist, potent D1 and D2 agonist
- only approved for treatment of hypomobility ("off" episodes)
- R-enantiomer
- equivalent to L-DOPA in treatment results
- Metabolism: extensive 1st pass
- AE: similar to L-DOPA, vomiting (give trimethobenzamide 3 days before), hypersexuality
Rotigotine
- DA receptor agonist, D1 D2 and D3 agonist
- Comes TD patch only
- Metabolism: N-dealkylation, sulfonation, glucuronidation
- AE: typical for this class
Cabergoline
- DA receptor agonist
- D2, D3, and potent 5HT2B (cardiotoxic) agonist
- Metabolism: minimal CYP involvement, hydrolysis of acyl urea
Anticholinergics
- Effective in early stages of Parkinsonism
- AE:
- Peripheral: tachychardia, can't see, can't pee, can't spit, can't sh*t
- CNS: somnelence, hallucinations, impared memory, delusions, ataxia, dysarthria
Anticholinergic Drugs
- Atropine
- Benztropine
- Procyclidine
- Diphenhydramine
- Trihexyphenidyl